Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Income towards Parent Company (2019 - 2025)

Historic Income towards Parent Company for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $67.1 million.

  • Strata Critical Medical's Income towards Parent Company rose 172610.94% to $67.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.3 million, marking a year-over-year increase of 19003.45%. This contributed to the annual value of -$27.3 million for FY2024, which is 5130.36% up from last year.
  • Latest data reveals that Strata Critical Medical reported Income towards Parent Company of $67.1 million as of Q3 2025, which was up 172610.94% from -$3.7 million recorded in Q2 2025.
  • Strata Critical Medical's Income towards Parent Company's 5-year high stood at $67.1 million during Q3 2025, with a 5-year trough of -$33.9 million in Q4 2023.
  • Over the past 5 years, Strata Critical Medical's median Income towards Parent Company value was -$7.8 million (recorded in 2021), while the average stood at -$3.7 million.
  • Per our database at Business Quant, Strata Critical Medical's Income towards Parent Company plummeted by 12980638.58% in 2021 and then surged by 172610.94% in 2025.
  • Over the past 5 years, Strata Critical Medical's Income towards Parent Company (Quarter) stood at $772000.0 in 2021, then crashed by 2096.76% to -$15.4 million in 2022, then plummeted by 120.18% to -$33.9 million in 2023, then surged by 45.27% to -$18.6 million in 2024, then soared by 461.07% to $67.1 million in 2025.
  • Its Income towards Parent Company stands at $67.1 million for Q3 2025, versus -$3.7 million for Q2 2025 and -$3.5 million for Q1 2025.